New Clinical Tools and Resources to Support Patients with Prolonged Symptoms and Concerns about Lyme Disease

At a glance

During this COCA Call, presenters will share a brief overview of Lyme disease, provide a diagnostic and management framework for patients with prolonged symptoms and concerns about Lyme disease, and review new clinical tools and resources to help support these patients.

Webinar

View slides - This content and conclusions are those of the author and presenter and do not necessarily represent the views of, nor should any endorsements be inferred by, the Centers for Disease Control and Prevention.

Free Continuing Education

Overview

Lyme disease is a bacterial tickborne disease that is treated with a short course of antibiotics. Most patients with Lyme disease recover fully after treatment, but about 5 to 10 percent can have prolonged symptoms such as fatigue, pain, and difficulty thinking, as a result of their infection. Some patients are concerned that their long-term symptoms may be due to Lyme disease and may take potentially harmful treatments, such as extended courses of antibiotics. The American Medical Association (AMA), in partnership with the Centers for Disease Control and Prevention (CDC), has developed a new toolkit to help clinicians provide better care for patients with prolonged, non-specific symptoms and concerns about Lyme disease. During this COCA Call, presenters will share a brief overview of Lyme disease, provide a diagnostic and management framework for patients with prolonged symptoms and concerns about Lyme disease, and review new clinical tools and resources to help support these patients.

Presenters

Erica Kaufman West, MD, FACP, FIDSA
Director of Infectious Diseases
American Medical Association

Grace Marx, MD, MPH, FIDSA
CDR, U.S. Public Health Service
Medical Officer, Bacterial Diseases Branch
Division of Vector-Borne Diseases
Centers for Disease Control and Prevention

Call Objectives

COCA Call Objectives

At the conclusion of the session, the participant will be able to accomplish the following:

  1. Cite background information on the topic covered during the presentation.
  2. Discuss CDC's role in the topic covered during the presentation.
  3. Describe the topic's implications for clinicians.
  4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
  5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.

Activity-Specific Objectives

  1. Describe the epidemiology and clinical presentation of Lyme disease.
  2. Describe what is known about acute and prolonged symptoms associated with Lyme disease.
  3. Outline clinical approaches, tools, and resources for healthcare providers caring for patients with prolonged symptoms and concerns about Lyme disease.

Additional Resources

Continuing Education

Instructions for Obtaining Continuing Education (CE)

To receive continuing education (CE) for WC4520R-091924—New Clinical Tools and Resources to Support Patients with Prolonged Symptoms and Concerns about Lyme Disease, please visit CDC TRAIN and search for the course in the Course Catalog using WC4520R-091924. Follow the steps below by October 21, 2024. The registration code is COCA091924.

To receive continuing education (CE) for WD4520R-091924—New Clinical Tools and Resources to Support Patients with Prolonged Symptoms and Concerns about Lyme Disease, please visit CDC TRAIN and search for the course in the Course Catalog using WD4520R-091924. Follow the steps below between October 22, 2024, and October 22, 2026.

  1. Register for and complete the course.
  2. Pass the post-assessment at 75%.
  3. Complete the evaluation.
  4. Visit Your Learning to access your certificates and transcript.

Accreditation Statements

In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Jointly Accredited Provider logo
CDC is a Jointly Accredited Provider of Interprofessional Continuing Education.

CME: The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA CME: Credit Designation Statement – Live
The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

CNE: The Centers for Disease Control and Prevention designates this activity for 1 nursing contact hours.

CPE: The Centers for Disease Control and Prevention designated this Knowledge-based event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-24-137-L04-P and enduring JA4008229-0000-24-138-H04-P.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEUs for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1. Continuing Competency credits available are 1. CDC provider number 98614.

AAVSB/RACE: This program has been submitted (but not yet approved) for 1 hours of continuing education credit in jurisdictions which recognize AAVSB RACE approval; however, participants should be aware that some boards have limitations on the number of hours accepted in certain categories or restrictions on certain methods of delivery of continuing education.

For Certified Public Health Professionals (CPH): The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credits for this program.

DISCLOSURE: In compliance with continuing education requirements, all planners and presenters/moderators must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.

CDC, our planners, and presenters/moderators wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Content will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.

Target Audience

  • Physicians
  • Nurses
  • Pharmacists
  • Veterinarians
  • Physician Assistants
  • Health Educators
  • Other Clinicians

Additional Information

  • Contact Information: coca@cdc.gov
  • Support/Funding: Centers for Disease Control and Prevention, Office of Emergency Risk Communication
  • Method of Participation: You may participate in the educational activity by viewing the program information above.
Print
Content Source: